Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2023 Readersâ Choice Winners
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Goodrx Holdings Inc Cl A
(NQ:
GDRX
)
7.230
+0.220 (+3.14%)
Streaming Delayed Price
Updated: 11:13 AM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Goodrx Holdings Inc Cl A
< Previous
1
2
3
4
5
6
7
8
9
Next >
Why GoodRx Surged Today
March 25, 2024
The prescription-drug upstart got an upgrade from Wall Street.
Via
The Motley Fool
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 25, 2024
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.
Via
Benzinga
Telemedicine GoodRx Has Potential To Excel, Close Valuation Gap By 2025, Analyst Says
March 25, 2024
Wells Fargo's upgrade of GoodRx Holdings. Analysts anticipate strong revenue visibility and EBITDA margins, setting the stage for potential stock outperformance in 2024-2025.
Via
Benzinga
The Latest Analyst Ratings For GoodRx Holdings
March 25, 2024
Via
Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
In-Depth Examination Of 4 Analyst Recommendations For GoodRx Holdings
February 26, 2024
Via
Benzinga
Unveiling 7 Analyst Insights On GoodRx Holdings
January 02, 2024
Via
Benzinga
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
March 25, 2024
U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) rose sharply in today’s pre-market trading.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
These Analysts Increase Their Forecasts On GoodRx Following Q4 Earnings
March 01, 2024
GoodRx Holdings, Inc. (NASDAQ: GDRX) reported upbeat fourth-quarter FY23 results and issued first-quarter revenue guidance above estimates.
Via
Benzinga
Why GoodRx Stock Soared Today
February 29, 2024
The company beat Q4 estimates, announced a new share repurchase authorization, and issued strong guidance.
Via
The Motley Fool
GoodRx (GDRX) Q4 2023 Earnings Call Transcript
February 29, 2024
GDRX earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Is Telemedicine Firm GoodRx's Shares Surging Today
February 29, 2024
GoodRx Holdings reported strong Q4 results and issued above-estimate revenue guidance for FY24. Revenue and adjusted EBITDA increased, company also announced new stock repurchase program.
Via
Benzinga
Where GoodRx Holdings Stands With Analysts
November 10, 2023
Via
Benzinga
GoodRx Holdings: Q3 Earnings Insights
November 09, 2023
Via
Benzinga
What 15 Analyst Ratings Have To Say About GoodRx Holdings
September 14, 2023
Via
Benzinga
13 Analysts Have This to Say About GoodRx Holdings
August 10, 2023
Via
Benzinga
Prescription Drug Discount Provider GoodRx Expects To Build Momentum In 2024, Stock Soars
January 10, 2024
GoodRx Holdings Inc (NASDAQ: GDRX) provided preliminary Q4 FY23 revenue of $195 million-$197 million, up 6%-7% Y/Y, versus the consensus of $190.77 million.
Via
Benzinga
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 10, 2024
Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.
Via
Benzinga
Election Edge: 7 Stocks to Snag Before the 2024 Presidential Race Heats Up
January 09, 2024
Election stocks include companies at the center of national conversation and those likely to get increased government funding.
Via
InvestorPlace
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 02, 2024
Shares of Longboard Pharmaceuticals, Inc.
Via
Benzinga
Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday
January 02, 2024
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
This Analyst With 84% Accuracy Rate Sees Around 22% Upside In NVIDIA - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
November 20, 2023
U.S. stocks closed slightly higher on Friday, with the S&P 500 notching gains for the third straight week. The S&P 500 gained 2.2% last week, while the Dow Jones ended the week with a 1.9% gain.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
HP To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
November 13, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page
Via
Benzinga
Why GoodRx Holdings Stock Dived by Nearly 19% Today
November 09, 2023
An unimpressive quarter featuring weak guidance led investors to hit the sell button.
Via
The Motley Fool
Why Is Telemedicine Firm GoodRx's Stock Trading Lower Today?
November 09, 2023
GoodRx Holdings Inc's (NASDAQ: GDRX) Q3 sales decreased 4% Y/Y to $180.0 million compared to $187.3 million, primarily due to a $10.0 million contract termination payment to a client, partially offset...
Via
Benzinga
GoodRx (GDRX) Q3 2023 Earnings Call Transcript
November 09, 2023
GDRX earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 09, 2023
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.
Via
Benzinga
These Analysts Boost Their Forecasts On GoodRx Holdings After Q2 Results
August 10, 2023
GoodRx Holdings Inc (NASDAQ: GDRX) reported better-than-expected second-quarter financial results.
Via
Benzinga
Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
August 10, 2023
Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023
August 10, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.